Yongbo Xiao
Papers
1
Total Citations
12
H-Index
1
About
Yongbo Xiao is a leading surgical oncologist whose research focuses on optimizing treatment strategies for rectal cancer, particularly through the integration of neoadjuvant chemoradiotherapy (nCRT) and minimally invasive surgery. His major contributions include conducting rigorous systematic reviews and Bayesian network meta-analyses that compare the short- and long-term outcomes of open, laparoscopic, and robotic surgery following nCRT. His landmark 2019 study, cited 12 times, provides critical evidence for surgeons and oncologists by synthesizing data from randomized controlled trials to clarify the comparative effectiveness and safety of these three surgical approaches. This work has helped guide clinical decision-making, highlighting the potential advantages of robotic and laparoscopic techniques in reducing complications while maintaining oncologic efficacy. Xiao’s research is notable for its methodological rigor, employing advanced statistical methods to address complex clinical questions. His findings have been influential in shaping contemporary surgical practice for rectal cancer, offering valuable insights for both researchers and clinicians seeking to improve patient outcomes through evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1